01541 Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

0 Analyst Rating

Wall Street analysts forecast 01541 stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for 01541 is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

0 Buy

0 Hold

0 Sell

Current: 6.110

Low

Averages

High

Current: 6.110

Low

Averages

High

No data

Valuation Metrics

The current forward P/E ratio for IMMUNEONCO-B (01541.HK) is -8.11, compared to its 5-year average forward P/E of -13.68. For a more detailed relative valuation and DCF analysis to assess IMMUNEONCO-B 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-13.68

Current PE

-8.11

Overvalued PE

-6.60

Undervalued PE

-20.75

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

-12.59

Current EV/EBITDA

-7.69

Overvalued EV/EBITDA

-5.51

Undervalued EV/EBITDA

-19.66

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

4483.75

Current PS

14.03

Overvalued PS

9102.80

Undervalued PS

-135.30

Financials

Annual

Quarterly

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

01541 News & Events

Events Timeline

No data

News

8.5

10-09aastocks

IMMUNEONCO-B Drops Over 12% Following Approximately 13% Discounted Share Placement

People Also Watch

Frequently Asked Questions

What is IMMUNEONCO-B (01541) stock price today?

The current price of 01541 is 6.11 USD — it has decreased -1.61 % in the last trading day.

What is IMMUNEONCO-B (01541)'s business?

What is the price predicton of 01541 Stock?

Wall Street analysts forecast 01541 stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for 01541 is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is IMMUNEONCO-B (01541)'s revenue for the last quarter?

IMMUNEONCO-B revenue for the last quarter amounts to NaN USD, decreased % YoY.

What is IMMUNEONCO-B (01541)'s earnings per share (EPS) for the last quarter?

IMMUNEONCO-B. EPS for the last quarter amounts to USD, decreased % YoY.

What changes have occurred in the market's expectations for IMMUNEONCO-B (01541)'s fundamentals?

The market is revising No Change the revenue expectations for 01541 for , with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by %.

How many employees does IMMUNEONCO-B (01541). have?

IMMUNEONCO-B (01541) has 0 emplpoyees as of December 16 2025.

What is IMMUNEONCO-B (01541) market cap?

Today 01541 has the market capitalization of 0.00 USD.